GENETIC CONTROL OF THE ANTIBODY RESPONSE

  • Hugh O. McDevitt
    From the National Institute for Medical Research, Mill Hill, London, England, and the Weizmann Institute of Science, Rehovoth, Israel
  • Michael Sela
    From the National Institute for Medical Research, Mill Hill, London, England, and the Weizmann Institute of Science, Rehovoth, Israel

この論文をさがす

抄録

<jats:p>Immunization of CBA and C57 mice with a branched, multichain synthetic polypeptide, poly (tyr,glu)-poly DL-ala--poly lys, ((T,G)-A--L), in Freund's complete adjuvant results in a tenfold or more difference in the antigen-binding capacity of sera from the two strains, although they respond equally to bovine serum albumin. Immunization of CBA x C57 F1, F1 x CBA, and F1 x C57 mice reveals definite genetic control of the response to (T,G)-A--L, which appears to be due to a single major genetic factor, with perhaps one or more modifying factors. Immunization of CBA and C57 mice with (H,G)-A--L, a synthetic polypeptide in which histidine replaces tyrosine, gives the opposite result, CBA's respond and C57's do not. From this, it appears that the genetic control of the response to (T,G)-A--L is specific for the antigenic determinant. The implications of these results are discussed.</jats:p>

収録刊行物

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ